Document Detail


MEK Inhibition in BRAF-Mutated Melanoma.
MedLine Citation:
PMID:  23034029     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
To the Editor: Although the efficacy of serine-threonine protein kinase (BRAF) inhibitors has been shown in patients with advanced melanoma who have the V600E BRAF mutation,(1),(2) data on the population with the V600K BRAF mutation are more limited and less encouraging. A phase 2 trial of vemurafenib showed a partial response in 4 of 10 patients with V600K BRAF mutations but provided no data on progression-free survival among these patients.(3) In the BREAK-2 (BRAF Inhibitor V600 E and K Metastatic Melanoma Phase 2) study of dabrafenib, the overall response rate and median progression-free survival were lower among 16 patients . . .
Authors:
Alex Mackenzie; Kym Boycott
Related Documents :
23885229 - Noonan syndrome: comparing mutation-positive with mutation-negative dutch patients.
23704059 - Deletion 16p13.11 uncovers nde1 mutations on the non-deleted homolog and extends the sp...
23506379 - Systematic molecular and cytogenetic screening of 100 patients with marfanoid syndromes...
12504739 - Myocilin glaucoma.
24092809 - Target-based therapeutic matching in early-phase clinical trials in patients with advan...
24936649 - Novel mutations in bmpr2, acvrl1 and kcna5 genes and hemodynamic parameters in patients...
19478349 - Interplay between human leukocyte antigen genes and the microbial colonization process ...
16504169 - Genetic variation in the myeloperoxidase gene and cognitive impairment in multiple scle...
23324949 - Hypertension-susceptibility gene prevalence in the pacific islands and associations wit...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The New England journal of medicine     Volume:  367     ISSN:  1533-4406     ISO Abbreviation:  N. Engl. J. Med.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0255562     Medline TA:  N Engl J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1364-5     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  MEK Inhibition in BRAF-Mutated Melanoma.
Next Document:  Early surgery for infective endocarditis.